Search research articles
Contact Us
Filters
Showing results (421-430 of 767) with videos related to
Page
of 77
Sort By:
FEMS Immunology and Medical Microbiology
|
February 19, 2003
Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting
Carlo Zanotto, Veronica Elli, Valeria Basavecchia, et al.
Tumori
|
December 31, 1992
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma
S Barni, P Lissoni, M Cazzaniga, et al.
The International Journal of Biological Markers
|
May 23, 2006
Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistance
P Lissoni, P Viganò, A Podraska, et al.
Cancer
|
March 15, 1993
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2
P Lissoni, S Pittalis, F Brivio, et al.
Pharmacological Research
|
June 23, 2025
Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes
Chiara Vantaggiato, Giulia Guarato, Francesca Brivio, et al.
In Vivo (Athens, Greece)
|
August 22, 2007
Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia
P Lissoni, F Brivio, L Fumagalli, et al.
Psychopharmacology
|
April 17, 2020
Chronic treatment with the antipsychotic drug blonanserin modulates the responsiveness to acute stress with anatomical selectivity
Francesca Marchisella, Maria Serena Paladini, Alice Guidi, et al.
British Journal of Cancer
|
January 1, 1994
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma
P Lissoni, S Barni, G Tancini, et al.
British Journal of Cancer
|
June 1, 1993
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract
P Lissoni, S Barni, G Tancini, et al.
Anticancer Research
|
May 16, 2009
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients
P Lissoni, F Brivio, L Fumagalli, et al.
Page
of 77
Search research articles
Search
Showing results (421-430 of 767) with videos related to
Sort By:
Page
of 77
FEMS Immunology and Medical Microbiology
|
February 19, 2003
Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting
Carlo Zanotto, Veronica Elli, Valeria Basavecchia, et al.
Tumori
|
December 31, 1992
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma
S Barni, P Lissoni, M Cazzaniga, et al.
The International Journal of Biological Markers
|
May 23, 2006
Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistance
P Lissoni, P Viganò, A Podraska, et al.
Cancer
|
March 15, 1993
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2
P Lissoni, S Pittalis, F Brivio, et al.
Pharmacological Research
|
June 23, 2025
Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes
Chiara Vantaggiato, Giulia Guarato, Francesca Brivio, et al.
In Vivo (Athens, Greece)
|
August 22, 2007
Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia
P Lissoni, F Brivio, L Fumagalli, et al.
Psychopharmacology
|
April 17, 2020
Chronic treatment with the antipsychotic drug blonanserin modulates the responsiveness to acute stress with anatomical selectivity
Francesca Marchisella, Maria Serena Paladini, Alice Guidi, et al.
British Journal of Cancer
|
January 1, 1994
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma
P Lissoni, S Barni, G Tancini, et al.
British Journal of Cancer
|
June 1, 1993
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract
P Lissoni, S Barni, G Tancini, et al.
Anticancer Research
|
May 16, 2009
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients
P Lissoni, F Brivio, L Fumagalli, et al.
Page
of 77